Nomizo, T.; Yamamoto, H.; Murayama, T.; Fukata, H.; Nakamura, Y.; Sonomura, M.; Okuno, A.; Kanda, N.; Watanabe, C.; Kita, H. Immune-Related Adverse Events Caused by Combined Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Lung Cancer. Trends Immunother. 2022, 6.